Search results
Results from the WOW.Com Content Network
Abbott began his transition to neuroscience research in 1989, joined the Department of Biology at Brandeis in 1993, and was the co-director of Brandeis Sloan Center for Theoretical Neurobiology from 1994 to 2002, the director of the Volen National Center for Complex Systems at Brandeis from 1997 to 2002, and a visiting faculty at UCSF Sloan ...
The Charlotte Research Institute (CRI) is a partnership between the University of North Carolina at Charlotte and corporations in the region. The goal of CRI is to develop technology-based academic and business partnerships, ranging from consultation to onsite collaborative research.
In normal brains and other tissues, the TDP-43 protein helps to ensure proper functioning of genes in the cell; the misfolded TDP-43 may thus impair normal gene expression regulation (so in LATE-NC, there is a loss-of-normal-function), and, the aberrant TDP-43 protein in LATE-NC may induce toxic gains of function also.
Legally, Atrium Health is The Charlotte-Mecklenburg Hospital Authority, [6] a municipal hospital authority established under North Carolina's Hospital Authorities Act (North Carolina General Statutes chapter 131E, part 2). The authority is governed by a self-perpetuating board of commissioners which nominates new commissioners to fill its own ...
The O'Berry Neuro-Medical Center is a public hospital in Goldsboro, North Carolina, United States, owned by the North Carolina Department of Health and Human Services. Its original goal was to help the intellectually disabled achieve independence by teaching them self-help skills and productive vocations. It has recently expanded its focus to ...
The North Carolina Biotechnology Center is a non-profit, public-private partnership organization located in Research Triangle Park (North Carolina, United States).Founded in 1984 by the North Carolina General Assembly, it was the first state-sponsored biotechnology initiative in the United States, merging the interests of the academic private and public sectors. [1]
Hongkui Zeng (fl. 2006), director of the Allen Institute for Brain Science, Seattle; Huda Zoghbi (born 1954), Lebanese-born American geneticist currently studying MECP2 and discovering that overexpressing the protein in mice led to an autism-like neurological disorder; Suzanne Zukin (fl. 2009), neuroscientist, studying glutamate receptors
He is board certified by the American Board of Neurological Surgery and a member of The Society of Neurological Surgeons. [2] Kim joined the Mischer Neuroscience Institute in October 2007, [3] where he served as Director until 2021. He has also held faculty and hospital appointments at Harvard Medical School, Brigham and Women's Hospital, the ...